ATE439051T1 - Zusammensetzungen und methoden zur verbesserung der vaskulären gesundheit - Google Patents

Zusammensetzungen und methoden zur verbesserung der vaskulären gesundheit

Info

Publication number
ATE439051T1
ATE439051T1 AT01926782T AT01926782T ATE439051T1 AT E439051 T1 ATE439051 T1 AT E439051T1 AT 01926782 T AT01926782 T AT 01926782T AT 01926782 T AT01926782 T AT 01926782T AT E439051 T1 ATE439051 T1 AT E439051T1
Authority
AT
Austria
Prior art keywords
methods
compositions
vascular health
improving vascular
polyphenols
Prior art date
Application number
AT01926782T
Other languages
English (en)
Inventor
Harold Schmitz
Kati Chevaux
Amy Dombroski
Ralph Jerome
Original Assignee
Mars Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22728187&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE439051(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mars Inc filed Critical Mars Inc
Application granted granted Critical
Publication of ATE439051T1 publication Critical patent/ATE439051T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/30—Cocoa products, e.g. chocolate; Substitutes therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/30—Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/32—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds
    • A23G1/42—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
    • A23G1/426—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing vitamins or antibiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/30—Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/32—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds
    • A23G1/48—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds or extracts
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/30—Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/56—Liquid products; Solid products in the form of powders, flakes or granules for making liquid products, e.g. for making chocolate milk, drinks and the products for their preparation, pastes for spreading or milk crumb
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
    • A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
    • A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
    • A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
    • A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
    • A23G3/48—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/111—Aromatic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A23K20/121—Heterocyclic compounds containing oxygen or sulfur as hetero atom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/168—Steroids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/577—Malvaceae (Mallow family)
    • A61K36/5777—Theobroma, e.g. cocao or cocoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G2200/00—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF containing organic compounds, e.g. synthetic flavouring agents
    • A23G2200/04—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF containing organic compounds, e.g. synthetic flavouring agents containing vitamins, antibiotics, other medicaments
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Husbandry (AREA)
  • Botany (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Zoology (AREA)
  • Cardiology (AREA)
  • Nutrition Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Birds (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Obesity (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
AT01926782T 2000-04-14 2001-04-10 Zusammensetzungen und methoden zur verbesserung der vaskulären gesundheit ATE439051T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19713500P 2000-04-14 2000-04-14
PCT/US2001/011542 WO2001078529A2 (en) 2000-04-14 2001-04-10 Compositions and methods for improving vascular health

Publications (1)

Publication Number Publication Date
ATE439051T1 true ATE439051T1 (de) 2009-08-15

Family

ID=22728187

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01926782T ATE439051T1 (de) 2000-04-14 2001-04-10 Zusammensetzungen und methoden zur verbesserung der vaskulären gesundheit

Country Status (17)

Country Link
US (2) US6610320B2 (de)
EP (1) EP1274319B1 (de)
JP (1) JP4970690B2 (de)
KR (1) KR20030005280A (de)
CN (1) CN1436047A (de)
AT (1) ATE439051T1 (de)
AU (1) AU2001253294A1 (de)
BR (1) BR0110084A (de)
CA (1) CA2405731C (de)
DE (1) DE60139550D1 (de)
ES (1) ES2331724T3 (de)
IL (1) IL152175A (de)
MX (1) MXPA02009956A (de)
PL (1) PL357822A1 (de)
RU (1) RU2303373C2 (de)
WO (1) WO2001078529A2 (de)
ZA (1) ZA200208130B (de)

Families Citing this family (96)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8507018B2 (en) * 1998-03-12 2013-08-13 Mars, Incorporated Products containing polyphenol(s) and L-arginine and methods of use thereof
US6562864B1 (en) * 1999-09-02 2003-05-13 Drake Larson Catechin multimers as therapeutic drug delivery agents
KR20030005280A (ko) * 2000-04-14 2003-01-17 마아즈, 인코오포레이티드 혈관의 건강을 개선하기 위한 조성물과 방법
JP2003534286A (ja) * 2000-05-26 2003-11-18 ホーファー リサーチ リミテッド 勃起障害症状改善のために、刺激物質の活性成分としてプロアントシアニジン、一酸化窒素源としてlアルギニン又はその塩の使用
FR2812873B1 (fr) * 2000-08-11 2003-08-01 Barry Callebaut France Procede de production de polyphenols a partir de feves de cacao
US20020076470A1 (en) 2000-10-31 2002-06-20 Colgate-Palmolive Company Composition and method
US8669282B2 (en) 2000-10-31 2014-03-11 Hill's Pet Nutrition, Inc. Companion animal compositions including lipoic acid and methods of use thereof
FI20010780A0 (fi) * 2001-04-12 2001-04-12 Raisio Benecol Oy Parannetut koostumukset
ITMI20011240A1 (it) * 2001-06-13 2002-12-13 Nicox Sa Farmaci per le vasculopatie
AU2002347165B2 (en) * 2001-12-11 2008-05-29 Ceapro Inc. Cereal beta glucan compositions, methods of preparation and uses thereof
US7514107B2 (en) 2002-03-21 2009-04-07 Mars, Incorporated Treatment of diseases involving defective gap junctional communication
WO2003099040A1 (en) * 2002-05-27 2003-12-04 Advance Holdings Limited Dietary supplements from wine vinasses and relevant production process
KR20030097398A (ko) * 2002-06-21 2003-12-31 이노천 양념육용 폴리페놀을 함유한 소스
JP4527938B2 (ja) * 2002-07-23 2010-08-18 オルビス株式会社 抗酸化用の経口投与組成物
KR100567389B1 (ko) * 2002-11-08 2006-04-04 (주)바이오뉴트리젠 폴리페놀계 물질 또는 바이오플라보노이드계 물질을 포함하는 식물의 분말 또는 추출물을 유효성분으로 포함하는 항비만용 탄수화물 식품
US20040258674A1 (en) * 2003-04-10 2004-12-23 Thunder Jalili Quercetin supplementation to treat hypertenstion
PL1795257T3 (pl) 2003-07-17 2013-10-31 Unilever Bcs Europe Bv Sposób stabilizowania jadalnej dyspersji zawierającej olej
US8463996B2 (en) * 2003-08-19 2013-06-11 Oracle America, Inc. Multi-core multi-thread processor crossbar architecture
WO2005027662A1 (en) * 2003-09-12 2005-03-31 Ray And Terry's Health Products, Inc. Meal replacement beverage
US7329429B2 (en) * 2003-09-25 2008-02-12 Chimel Mark J Bars and confectioneries containing cocoa solids having a high cocoa polyphenol content and sterol/stanol esters and processes for their preparation
US7160771B2 (en) * 2003-11-28 2007-01-09 International Business Machines Corporation Forming gate oxides having multiple thicknesses
EP1713467B1 (de) * 2004-01-28 2012-08-01 Mars, Incorporated Zusammensetzungen und verfahren zur verwendung von procyanidinen vom a-typ
CA2794424C (en) * 2004-03-29 2019-06-04 Wyeth Llc Multi-vitamin and mineral nutritional supplements
KR100656241B1 (ko) 2004-09-10 2006-12-11 롯데제과주식회사 고지혈증 및 혈소판 응집에 대해 억제작용을 갖는대두발효 추출물과 이를 이용한 조성물
JP2006087352A (ja) * 2004-09-24 2006-04-06 Meiji Seika Kaisha Ltd Ldl酸化抑制組成物
WO2006061915A1 (ja) * 2004-12-09 2006-06-15 Toyo Shinyaku Co., Ltd. 皮膚改善組成物
WO2006063219A2 (en) * 2004-12-09 2006-06-15 Pro-Health, Inc. Product and method for oral administration of nutraceuticals
US20060134235A1 (en) * 2004-12-22 2006-06-22 Toyo Shinyaku Co., Ltd. External preparation for improving blood flow
BRPI0519642A8 (pt) 2004-12-29 2017-10-03 Hill´S Pet Nutrition Inc Método para inibir um declínio em aprendizagem e/ou memória, kit apropriado para administrar um ou mais antioxidantes a um animal, meio para transmitir informação, e, uso de uma composição
EP1850676A1 (de) 2005-02-17 2007-11-07 Unilever N.V. Granulat mit sterol
US7252834B2 (en) * 2005-04-25 2007-08-07 Clemson University Research Foundation (Curf) Elastin stabilization of connective tissue
JP2008542305A (ja) * 2005-06-03 2008-11-27 ホリズン サイエンス ピーティーワイ リミテッド 配送システム
US20060293259A1 (en) * 2005-06-28 2006-12-28 Mars, Incorporated Compositions and methods of use of derivatized flavanols
AU2006263669B9 (en) * 2005-06-29 2012-12-13 Mars, Incorporated Inducing peripheral blood vessel vasodilation
BRPI0613000A2 (pt) 2005-07-14 2012-12-04 Hills Pet Nutrition Inc método para aumentar a longevidade de um animal, artigo de fabricação, kit, e, meio de comunicação de informação acerca de ou instruções para a administração a um animal velho de uma composição
KR100712651B1 (ko) * 2005-07-29 2007-05-02 담양군 초콜릿 조성물 및 그 제조방법
US20070026126A1 (en) * 2005-08-01 2007-02-01 Bryan Hitchcock Sterol fortified beverages
WO2007024770A2 (en) * 2005-08-22 2007-03-01 Archer-Daniels-Midland Company Methods of forming phytosterol-fortified cocoa powder and the product formed therefrom
EP2275096A3 (de) 2005-08-26 2011-07-13 Braincells, Inc. Neurogenese durch modulation des Muscarinrezeptors
AU2011221341B2 (en) * 2005-08-26 2013-11-28 Nestec S.A. Compositions and methods for improving functional vascular integrity, cellular survival and reducing apoptosis in ischemia or after ischemic episode in the brain
EP2258357A3 (de) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenese mit Acetylcholinesterasehemmer
US20070053955A1 (en) * 2005-08-26 2007-03-08 Nestec S.A. Compositions and methods for improving cellular survival and reducing apoptosis after ischemic episode in the brain
WO2007047978A2 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by pde inhibition
EP2314289A1 (de) 2005-10-31 2011-04-27 Braincells, Inc. Gaba-rezeptor-vermittelte modulation von neurogenese
US20070104762A1 (en) * 2005-11-04 2007-05-10 Roizen Michael F Appetizer supplement to suppress age-related decline in capacity and appetite
US7976879B2 (en) * 2005-11-04 2011-07-12 Roizen Michael F Nutritional supplement product to suppress age-related decline in cognitive capacity and other aging functions
ES2281270B1 (es) * 2005-11-30 2008-07-01 La Morella Nuts, S.A. Alimento funcional con efectos positivos en la prevencion de enfermedades cardiovasculares.
JP4807563B2 (ja) * 2005-12-06 2011-11-02 株式会社 伊藤園 容器詰め飲料及びその製造方法
EP2004208B1 (de) * 2005-12-23 2017-01-25 Mars, Incorporated Hautschutz und -verbesserung
US20070219146A1 (en) * 2006-02-06 2007-09-20 Sunil Bhaskaran Synergistic Pharmaceutical And/Or Neutraceutical Flavanoid Composition For Management Of Diabetes Mellitus
JP2009527487A (ja) * 2006-02-16 2009-07-30 ザ ハーシー カンパニー ココア製品及び心血管状態を無糖ココアで処置する方法
US20070218113A1 (en) * 2006-02-28 2007-09-20 Miller Debra L Health bars and compositions for improving cardiovascular risk factors
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
CA2643199A1 (en) * 2006-03-08 2007-09-13 Braincells, Inc. Modulation of neurogenesis by nootropic agents
JP5251504B2 (ja) * 2006-03-31 2013-07-31 不二製油株式会社 蛋白含有油性食品
EP1844664B1 (de) * 2006-04-10 2009-12-02 Barilla G. e R. Fratelli S.p.A. Nahrungsmittelriegel enthaltend funktionelle Zutaten (Vitamin C und E, Catechine) zur Verhinderung von Degenerationphänomenen, die durch Oxidationsmitteln verursacht werden
US8110231B2 (en) * 2006-04-10 2012-02-07 Kraft Foods Global Brands Llc Methods for making improved texture cereal bars
US20100009983A1 (en) * 2006-05-09 2010-01-14 Braincells, Inc. 5 ht receptor mediated neurogenesis
EP2021000A2 (de) 2006-05-09 2009-02-11 Braincells, Inc. Neurogenese mittels angiotensin-modulation
US7678808B2 (en) 2006-05-09 2010-03-16 Braincells, Inc. 5 HT receptor mediated neurogenesis
US8084065B2 (en) * 2006-05-29 2011-12-27 Fenchem Enterprises, Ltd Compositions for treating and preventing hyperlipidemia
US8821947B2 (en) * 2006-06-01 2014-09-02 Howard W. Selby, III Cholesterol-reducing diet
US20070299017A1 (en) * 2006-06-23 2007-12-27 Kanter Mitchell M Compositions for lowering blood serum cholesterol and use in foods, beverages, and health supplements
WO2008030651A1 (en) * 2006-09-08 2008-03-13 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
EP2066355A2 (de) * 2006-09-19 2009-06-10 Braincells, Inc. Kombination aus einem durch einen peroxisom-proliferator aktivierten rezeptor-mittel und einem zweiten neurogenen mittel zur behandlung von erkrankungen des nervensystems sowie zur förderung von neuraler differenzierung und neurogenese
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US9114114B2 (en) 2007-06-21 2015-08-25 Mars, Inc. Edible products having a high cocoa polyphenol content and improved flavor and the milled cocoa extracts used therein
EP2033526A1 (de) * 2007-09-07 2009-03-11 Probelte Pharma, S.A. Nahrungsmittel mit ellagitanninhaltigen Granatapfelextrakten und ihre Verwendung
KR101290514B1 (ko) * 2007-10-25 2013-07-26 뉴트리 가부시키가이샤 혈중의 당, 말론디알데히드 수식 ldl, 호모시스테인 및/또는 c 반응성 단백질을 저감시키기 위한 조성물
US20090155337A1 (en) * 2007-11-12 2009-06-18 Endologix, Inc. Method and agent for in-situ stabilization of vascular tissue
GB0801119D0 (en) 2008-01-22 2008-02-27 Barry Callebaut Ag Composition
EP2090178A1 (de) * 2008-02-13 2009-08-19 Bühler AG Haustier-Nahrungsmittelprodukt und Verfahren zu seiner Herstellung
JP2011513220A (ja) * 2008-02-21 2011-04-28 ヴァトリックス・メディカル・インコーポレーテッド デリバリービヒクルと組み合わせた結合組織安定剤の適用による動脈瘤の処置
US20100016833A1 (en) * 2008-07-15 2010-01-21 Ogle Matthew F Devices for the Treatment of Vascular Aneurysm
US20100055249A1 (en) * 2008-08-29 2010-03-04 Tropicana Products, Inc. Naturally sweetened juice beverage products with beta-glucan
US20100119605A1 (en) * 2008-11-12 2010-05-13 Isenburg Jason C Compositions for tissue stabilization
HUE033526T2 (en) 2008-12-19 2017-12-28 Unilever Bcs Europe Bv Edible fat powders
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
JP5569716B2 (ja) * 2009-06-23 2014-08-13 独立行政法人国立循環器病研究センター レクチン様酸化ldl受容体阻害用医薬品
EP2453759B1 (de) * 2009-07-14 2015-10-21 Hill's Pet Nutrition, Inc. Haustierfuttermittel enthaltend einer verzögerten freisetzung form von liponsäure, deren verwendung und herstellungsverfahren
KR101323491B1 (ko) * 2009-08-11 2013-10-31 인두스 바이오텍 프라이빗 리미티드 새로운 표준 조성물, 제조 방법 및 rna 바이러스 감염의 해결을 위한 용도
WO2011044455A1 (en) * 2009-10-09 2011-04-14 Vatrix Medical, Inc. In vivo chemical stabilization of vulnerable plaque
US8444624B2 (en) * 2009-10-19 2013-05-21 Vatrix Medical, Inc. Vascular medical devices with sealing elements and procedures for the treatment of isolated vessel sections
US9924730B2 (en) 2010-06-22 2018-03-27 Unilever Bcs Us, Inc. Edible fat powders
ES2372381B1 (es) * 2010-06-29 2012-11-28 La Morella Nuts, S.A. Ingrediente reconstituido de fruto seco y/o algarroba.
MX337914B (es) 2010-12-17 2016-03-28 Unilever Nv Proceso para compactar polvo de grasa microporosa y polvo de grasa compactado asi obtenido.
MX342040B (es) 2010-12-17 2016-09-12 Unilever Nv Emulsion de agua en aceite comestible.
FR2969496B1 (fr) * 2010-12-22 2013-11-08 Expanscience Lab Extrait de pulpe et/ou de peau d'avocat riche en polyphenols et compositions cosmetiques, dermatologiques et nutraceutiques le comprenant
US8911468B2 (en) 2011-01-31 2014-12-16 Vatrix Medical, Inc. Devices, therapeutic compositions and corresponding percutaneous treatment methods for aortic dissection
JP2012213339A (ja) * 2011-03-31 2012-11-08 Lotte Co Ltd 植物性ステロール配合チョコレートおよびその製造方法
US9937255B2 (en) 2011-05-18 2018-04-10 Nectero Medical, Inc. Coated balloons for blood vessel stabilization
WO2012171001A2 (en) * 2011-06-10 2012-12-13 Ambo Innovations, Llc Food products containing beta-glucans and omega-3 fatty acids
US9283241B2 (en) 2012-07-10 2016-03-15 Clemson University Treatment to render implants resistant to diabetes
JP6772064B2 (ja) * 2014-10-17 2020-10-21 株式会社明治 ポリフェノール含有機能性経口組成物
US11173187B2 (en) * 2018-11-13 2021-11-16 Immortazyme Company Ltd. Concentrated oil-based polyphenol composition and a method of producing the oil-based polyphenol composition
US20220378771A1 (en) * 2021-05-25 2022-12-01 Louis Habash Modifying the expression level of a gene encoding an cyclooxygenase enzyme by treating a human subject with a nitroxide

Family Cites Families (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1099627A (en) 1975-09-11 1981-04-21 David J. Horvath Piezoelectric ignition system for gas burners
WO1983001924A1 (en) 1981-12-03 1983-06-09 Acf Ind Inc Filament wound vessel
US4883788A (en) * 1986-06-06 1989-11-28 Hauser-Kuhrts, Inc. Method and composition for reducing serum cholesterol
US4808574A (en) 1986-12-03 1989-02-28 Nauchno-Issledovatelsky Institut Sadovodstva Composition inhibiting pathological addiction to alcohol
IT1201151B (it) * 1987-01-14 1989-01-27 Indena Spa Complessi fosfolipidici con estratti da vitis vinifera,procedimento per la loro preparazione e composizioni che li cntengono
JPS63214183A (ja) * 1987-03-03 1988-09-06 Mitsui Norin Kk アンジオテンシン1変換酵素阻害剤
DE4102054A1 (de) * 1991-01-24 1992-07-30 Geb Szenasi Tamas Verwendung der pflanze euphorbia hirta l. und ihrer extrakte sowie ihrer wirkstoffe
EP0594612B2 (de) 1991-05-03 2010-02-24 Raisio Nutrition Ltd. Verfahren zur Herstellung einer Substanz enthaltend einen beta-Sitostanol-Fettsäureester oder eine Mischung enthaltend einen solchen
US5244887A (en) 1992-02-14 1993-09-14 Straub Carl D Stanols to reduce cholesterol absorption from foods and methods of preparation and use thereof
CN1099627A (zh) * 1993-08-30 1995-03-08 江苏省肿瘤防治研究所 一种用松针制备抗癌扶正冲剂的方法
GB9319943D0 (en) * 1993-09-28 1993-11-17 Solvay Interox Ltd Thickened compositions
US5554645A (en) 1994-10-03 1996-09-10 Mars, Incorporated Antineoplastic cocoa extracts and methods for making and using the same
FI955691A7 (fi) 1994-11-28 1996-05-29 Suntory Ltd Lipoproteiini(a):ta alentava aine, kolesterolia alentava aine ja näitä aineita sisältävät lääkkeet
DE69633502T2 (de) * 1995-12-26 2006-02-23 Suntory Ltd. Procyanidin als den aktiven bestandteil enthaltende mittel gegen fettleibigkeit
JPH09291039A (ja) * 1995-12-26 1997-11-11 Suntory Ltd プロシアニジンを有効成分とする抗肥満剤
US5702752A (en) 1996-03-13 1997-12-30 Archer Daniels Midland Company Production of isoflavone enriched fractions from soy protein extracts
US6469053B1 (en) * 1996-04-02 2002-10-22 Mars Incorporated Use of procyanidins in the maintenance of vascular health and modulation of the inflammatory response
US6297273B1 (en) * 1996-04-02 2001-10-02 Mars, Inc. Use of cocoa solids having high cocoa polyphenol content in tabletting compositions and capsule filling compositions
CN1159019C (zh) * 1996-04-02 2004-07-28 火星有限公司 可提取物化合物以及其制备方法和用途
CN1226805A (zh) 1996-04-09 1999-08-25 纳幕尔杜邦公司 新型富含异黄酮的大豆蛋白产品及其生产方法
FI107015B (fi) 1996-08-09 2001-05-31 Raisio Benecol Oy Kasvistanolirasvahappoestereiden seos ja sen käyttö sekä elintarvike
US6015913A (en) * 1996-09-06 2000-01-18 Mars, Incorporated Method for producing fat and/or solids from cocoa beans
US6312753B1 (en) * 1996-09-06 2001-11-06 Mars, Incorporated Cocoa components, edible products having enriched polyphenol content, methods of making same and medical uses
FI105887B (fi) 1996-09-27 2000-10-31 Suomen Sokeri Oy Elintarvike- ja terapeuttisiin sovelluksiin käyttökelpoiset, kasvisterolia sisältävät tuotteet, menetelmä niiden valmistamiseksi ja niiden käyttö
FI120290B (fi) * 1996-12-30 2009-09-15 Mirador Res Oy Ltd Menetelmä, jonka avulla voidaan valmistaa sellaisia mausteseos-, ruoan ainesosa- ja elintarvikekoostumuksia, jotka alentavat seerumin kolesterolia
EP1021177A4 (de) * 1997-02-04 2002-05-15 John V Kosbab Zusammensetzungen und verfahren zur verhütung und behandlung von vaskulär-degeneratieve krankheiten
FI108110B (fi) 1997-06-13 2001-11-30 Danisco Finland Oy Elintarvike- ja eläinravitsemusalalla käyttökelpoinen esiseos, menetelmä sen valmistamiseksi ja sen käyttö
WO1998057545A1 (en) * 1997-06-17 1998-12-23 Rutgers, The State University Of New Jersey Hypocholesterolemic compositions from bamboo shoots
ES2229443T3 (es) 1997-08-22 2005-04-16 Unilever N.V. Procedimiento para la produccion de esteres de estanol.
EP1298194B1 (de) 1997-08-22 2006-10-04 Unilever N.V. Stanolester enthaltende Zusammensetzungen
US6126943A (en) 1997-09-02 2000-10-03 The Ricex Company Method for treating hypercholesterolemia, hyperlipidemia, and atherosclerosis
FI974648A7 (fi) 1997-09-09 1999-05-06 Raisio Benecol Oy Hydroksihappo-, maitohappo- ja hydroksialkanoaattiesterit ja niiden käyttö
US6054128A (en) * 1997-09-29 2000-04-25 Wakat; Diane Dietary supplements for the cardiovascular system
US5952374A (en) 1997-09-29 1999-09-14 Protein Technologies International, Inc. Method for inhibiting the development of Alzheimer's disease and related dementias- and for preserving cognitive function
US6228993B1 (en) 1998-10-12 2001-05-08 Central Soya Company, Inc. Soy isoflavone concentrate process and product
US6394230B1 (en) 1997-12-16 2002-05-28 Cognis Corporation Sterol esters as food additives
US5985936A (en) 1997-12-18 1999-11-16 Forbes Medi-Tech, Inc. Method of preventing and delaying onset of Alzheimer's disease and composition therefor
FI109327B (fi) 1998-02-27 2002-07-15 Spice Sciences Oy Menetelmä seerumin kokonais- ja LDL-kolestrolipitoisuutta alentavan beta-sitosterolin rasvamaisen seoksen valmistamiseksi
US6132795A (en) 1998-03-15 2000-10-17 Protein Technologies International, Inc. Vegetable protein composition containing an isoflavone depleted vegetable protein material with an isoflavone containing material
AT407821B (de) * 1998-03-24 2001-06-25 Franz Dr Stueckler Mittel auf der basis von naturstoffen
US6025348A (en) 1998-04-30 2000-02-15 Kao Corporation Oil and fat composition containing phytosterol
WO1999053925A1 (en) 1998-04-17 1999-10-28 Medical Isotopes Inc. Phytosterol formulations to lower cholesterol absorption
SE512958C2 (sv) 1998-04-30 2000-06-12 Triple Crown Ab Kolesterolsänkande komposition innehållande beta-sitosterol och/eller beta-sitostanol samt förfarande för dess framställning
US6087353A (en) 1998-05-15 2000-07-11 Forbes Medi-Tech Inc. Phytosterol compositions and use thereof in foods, beverages, pharmaceuticals, nutraceuticals and the like
US5932562A (en) 1998-05-26 1999-08-03 Washington University Sitostanol formulation to reduce cholesterol absorption and method for preparing and use of same
CA2334449A1 (en) * 1998-06-05 1999-12-16 Radka K. Milanova Compositions comprising phytosterol, phytostanol or mixtures of both having enhanced solubility and dispersability and incorporation thereof into foods, beverages, pharmaceuticals, nutraceuticals and the like
US6013771A (en) 1998-06-09 2000-01-11 Protein Technologies International, Inc. Isoflavone rich protein isolate and process for producing
US6150399A (en) 1998-06-30 2000-11-21 Abbott Laboratories Soy-based nutritional products
US5892068A (en) 1998-08-25 1999-04-06 Mcneil-Ppc, Inc. Preparation of sterol and stanol-esters
AU5612199A (en) 1998-09-10 2000-04-03 Forbes Medi-Tech Inc. Compositions comprising one or more phytosterols, phytostanols or mixtures of both and one or more alpha, beta, delta, or gamma tocotrienols or derivatives thereof and use of the compositions in treating or preventing cardiovascular disease, its underlying conditions and other
WO2000024266A2 (en) 1998-10-26 2000-05-04 Galagen, Inc. Soy and immunoglobulin compositions
ATE398935T1 (de) 1998-11-09 2008-07-15 Taiyo Kagaku Kk Zusatz zur verbesserung der gefluegelproduktivitaet sowie verfahren zur verbesserung der gefluegelproduktivitaet
US6509043B1 (en) 1998-11-25 2003-01-21 Nutri Pharma Asa Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of pulmonary diseases
AU767245B2 (en) 1998-11-25 2003-11-06 Nutri Pharma Asa Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of cardiovascular diseases
CA2352510A1 (en) 1998-11-25 2000-06-02 Nutri Pharma Asa Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of type 2 diabetes, the metabolic syndrome and associated cardiovascular diseases
US6242001B1 (en) 1998-11-30 2001-06-05 Mcneil-Ppc, Inc. Method for producing dispersible sterol and stanol compounds
US6592910B1 (en) 1999-04-20 2003-07-15 Board Of Trustees, Southern Illinois University Methods of treating clinical diseases with isoflavones
US6544566B1 (en) 1999-04-23 2003-04-08 Protein Technologies International, Inc. Composition containing plant sterol, soy protein and isoflavone for reducing LDL cholesterol
US5972345A (en) 1999-05-03 1999-10-26 Chizick; Stephen Natural preparation for treatment of male pattern hair loss
US6426112B1 (en) 1999-07-23 2002-07-30 University Of Kentucky Research Foundation Soy products having improved odor and flavor and methods related thereto
NZ505933A (en) 1999-07-26 2002-11-26 Mcneil Ppc Inc Incorporation of cholesterol lowering agents into confectionery dosage forms
US6313273B1 (en) 1999-08-25 2001-11-06 Abbott Laboratories Soy proteins and methods for their production
WO2001026668A1 (en) 1999-10-14 2001-04-19 Unilever N.V. Compositions with anti-prostate cancer activity
WO2001037781A2 (en) 1999-10-28 2001-05-31 Ingredient Innovations International A stable aqueous dispersion of nutrients
AU1260801A (en) * 1999-11-03 2001-05-14 Forbes Medi-Tech Inc. Compositions comprising edible oils or fats and phytosterols and/or phytostanolssubstantially dissolved therein, method of making the same, and use thereof in treating or preventing cardiovascular disease and its underlying conditions
US6207702B1 (en) * 1999-11-17 2001-03-27 Mars, Incorporated Method for reducing postprandial oxidative stress using cocoa procyanidins
FI20000004A0 (fi) 2000-01-03 2000-01-03 Slk Foundation Flavonoidilääke...
WO2001051088A1 (en) 2000-01-07 2001-07-19 Anthony Cincotta Composition for reducing plasma triglycerides, platelet aggregation, and oxidative capacity
KR20030005280A (ko) 2000-04-14 2003-01-17 마아즈, 인코오포레이티드 혈관의 건강을 개선하기 위한 조성물과 방법
DE60118398T2 (de) 2000-08-18 2006-12-07 Solae Holdings Llc Sojaproteinprodukt und verfahren zur herstellung

Also Published As

Publication number Publication date
ZA200208130B (en) 2004-01-22
ES2331724T3 (es) 2010-01-14
RU2002130509A (ru) 2004-03-27
RU2303373C2 (ru) 2007-07-27
AU2001253294A1 (en) 2001-10-30
IL152175A (en) 2005-08-31
PL357822A1 (pl) 2004-07-26
JP4970690B2 (ja) 2012-07-11
CA2405731A1 (en) 2001-10-25
WO2001078529A2 (en) 2001-10-25
US20040081715A1 (en) 2004-04-29
EP1274319A2 (de) 2003-01-15
CN1436047A (zh) 2003-08-13
WO2001078529A3 (en) 2002-03-21
CA2405731C (en) 2012-09-18
MXPA02009956A (es) 2003-02-12
EP1274319B1 (de) 2009-08-12
BR0110084A (pt) 2002-12-31
US20020018807A1 (en) 2002-02-14
KR20030005280A (ko) 2003-01-17
IL152175A0 (en) 2003-05-29
US6610320B2 (en) 2003-08-26
JP2003530410A (ja) 2003-10-14
DE60139550D1 (de) 2009-09-24

Similar Documents

Publication Publication Date Title
DE60139550D1 (de) Zusammensetzungen und methoden zur verbesserung der vaskulären gesundheit
EP2332527A3 (de) Flavanoide und Isoflavanoide für die Prävention und Behandlung von kardiovaskulären Erkrankungen
IL183953A0 (en) Method of reducing oxidant induced damage of a food product, a pharmaceutical, or stored blood
MY127247A (en) New pharmaceutical composition
WO2001068135A3 (en) Compositions and methods for affecting osteogenesis
WO2002081651A3 (en) Polyphenolics for enhancing endothelial cell-mediated fibrinolysis
MXPA04001523A (es) Dialdehidos de rapamicina.
BG101446A (bg) Антинеопластични какаови екстракти, метод за получаване и използване
IS6557A (is) Blandaðar sjúkdómsmeðferðir úr blóðþrýstingslækkandi efnum og efnum sem hamla æðamyndun
ATE371475T1 (de) Methoden zur behandlung der hautpigmentierung
UA88463C2 (ru) Фармацевтическая композиция, которая содержит соединение 1, и процесс лечения вич-инфекции
MXPA04001524A (es) 29-enoles de rapamicina.
MXPA04005517A (es) Composiciones farmaceuticas bajo forma de gel o solucion a base de dihidrotestosterona, su metodo de preparacion y sus usos.
IL185539A0 (en) Hydrazinocarbonyl-thieno[2,3-c]pyrazoles, preparation method compositions containing same and use
PT1109571E (pt) Metodos de tratamento da hipertensao e composicoes para utilizacao nesses metodos
YU12903A (sh) Derivati aminoalkenilbenzoil-benzofurana ili benzotiopena, postupak za njihovo pripremanje i kompozicije koje ih sadrže
WO2001089520A3 (en) Dehydroascorbic acid formulations and uses thereof
MXPA03001536A (es) (aminoalcoxibenzoil) benzofuranos o benzotiofenos, metodo para preparar los mismo y composiciones que los contienen.
WO2003012051A3 (en) Inhibitor of dna methylation
IL144199A0 (en) Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
DE60134702D1 (de) Mischungen von Isoflavonen und Flavonen
BR0111785A (pt) Composições e métodos para tratamento de candidìase
NO20060420L (no) 2-aminobenzoylderivater
BR0313186A (pt) Agente redutor de colesterol proveniente de fibra alimentar e substâncias redutoras de colesterol
DE60041198D1 (de) Antimikrobielle zusammensetzungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties